GW & Wade’s Vanguard Total International Stock ETF VXUS Stock Holding History

GW & Wade’s Portfolio VXUS Stock Details VXUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,837	Closed	-$313K	–	410
2022 Q3	$313K	Buy	+6,837	New	+$350K	0.02%	296

Other funds holding VXUS

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GWA

Gibson Wealth Advisors Tyler, Texas $160M AUM 20.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

GW & Wade's VXUS Position: Q4 2022 in Review

GW & Wade sold out of Vanguard Total International Stock ETF (VXUS) in Q4 2022, closing a stake of 6,837 shares — an estimated $313K sold.

GW & Wade first reported a position in VXUS in Q3 2022 and held it in 1 quarter. The position peaked at $313K in Q3 2022. 918 funds tracked by Wall St. Rank hold VXUS as of Q4 2022.

GW & Wade reported no remaining Vanguard Total International Stock ETF position as of Q4 2022 after selling out during the quarter.
GW & Wade sold 6,837 Vanguard Total International Stock ETF shares in Q4 2022, an estimated $313K.
GW & Wade first reported a position in Vanguard Total International Stock ETF in Q3 2022 and held it in 1 quarter.
GW & Wade's Vanguard Total International Stock ETF position peaked at $313K in Q3 2022.
918 funds tracked by Wall St. Rank held Vanguard Total International Stock ETF as of Q4 2022.

Based on GW & Wade's 13F filing for Q4 2022, filed 10 Feb 2023.